Gofen & Glossberg’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-27,170
Closed -$1.02M 439
2019
Q4
$1.02M Buy
27,170
+1,247
+5% +$56K 0.03% 214
2019
Q3
$1.21M Sell
25,923
-3,047
-11% -$142K 0.04% 196
2019
Q2
$1.51M Sell
28,970
-1,175
-4% -$68.9K 0.05% 181
2019
Q1
$2.08M Sell
30,145
-1,289
-4% -$86.4K 0.07% 159
2018
Q4
$1.88M Sell
31,434
-24,920
-44% -$2.15M 0.07% 162
2018
Q3
$6.53M Sell
56,354
-1,734
-3% -$196K 0.22% 100
2018
Q2
$7.33M Buy
58,088
+463
+0.8% +$56.4K 0.27% 93
2018
Q1
$6.24M Sell
57,625
-1,825
-3% -$202K 0.23% 99
2017
Q4
$6.51M Buy
59,450
+2,056
+4% +$205K 0.23% 100
2017
Q3
$5.67M Buy
57,394
+5,192
+10% +$503K 0.21% 105
2017
Q2
$5.29M Buy
52,202
+21,746
+71% +$2.34M 0.2% 103
2017
Q1
$3.52M Buy
30,456
+12,223
+67% +$1.42M 0.14% 123
2016
Q4
$2.19M Buy
18,233
+3,594
+25% +$398K 0.09% 155
2016
Q3
$1.64M Buy
14,639
+177
+1% +$20.4K 0.07% 174
2016
Q2
$1.79M Buy
14,462
+391
+3% +$47.2K 0.08% 170
2016
Q1
$1.58M Buy
14,071
+2,852
+25% +$296K 0.07% 174
2015
Q4
$1.22M Buy
11,219
+2,391
+27% +$274K 0.05% 186
2015
Q3
$881K Buy
8,828
+7,010
+386% +$762K 0.04% 215
2015
Q2
$207K Buy
+1,818
New +$220K 0.01% 425

Other funds holding CLB

Gofen & Glossberg's CLB Position: Q1 2020 in Review

Gofen & Glossberg sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 27,170 shares — an estimated $1.02M sold.

Gofen & Glossberg first reported a position in CLB in Q2 2015 and held it in 19 quarters. The position peaked at $7.33M in Q2 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Gofen & Glossberg reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Gofen & Glossberg sold 27,170 Core Laboratories shares in Q1 2020, an estimated $1.02M.
  • Gofen & Glossberg first reported a position in Core Laboratories in Q2 2015 and held it in 19 quarters.
  • Gofen & Glossberg's Core Laboratories position peaked at $7.33M in Q2 2018.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Gofen & Glossberg's 13F filing for Q1 2020, filed 14 Apr 2020.